# Remimazolam Versus Dexmedetomidine for Sedation During Neuraxial

> **NCT07651956** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 150 (estimated)

## Conditions studied

- Pregnant People
- Anxiety

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT07651956
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-25
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07651956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07651956, "Remimazolam Versus Dexmedetomidine for Sedation During Neuraxial". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07651956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*